Related Experiment Video

Updated: Aug 18, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Immunostimulatory CpG oligodeoxynucleotides and antibody therapy of cancer

Bernd Jahrsdörfer1, George J Weiner

  • 1Holden Comprehensive Cancer Center, Department of Internal Medicine, Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, USA.

Seminars in Oncology
|August 27, 2003
PubMed

Insights

Synthetic oligodeoxynucleotides containing CG motifs (CpG ODN) show promise as cancer immunotherapies. CpG ODN can activate immune cells and enhance the effectiveness of cancer treatments like monoclonal antibody therapy.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Synthetic oligodeoxynucleotides with CG motifs (CpG ODN) possess strong immunostimulatory properties.
  • CpG ODN have potential applications in cancer immunotherapy.
  • Animal models indicate CpG ODN activate immune cells like natural killer (NK) cells.

Purpose of the Study:

  • To explore the potential of CpG ODN as immunotherapeutic agents in cancer.
  • To investigate CpG ODN's role in enhancing tumor immunization and activating antigen-presenting cells.
  • To assess CpG ODN's ability to modify malignant B-cell antigens and immune cell interactions.

Main Methods:

  • Utilizing animal models to evaluate CpG ODN effects on immune cells and tumor immunization.
  • Investigating CpG ODN's impact on antigen expression in malignant B-cells.
  • Assessing CpG ODN's potential to enhance antibody-dependent cellular cytotoxicity (ADCC).

Main Results:

  • CpG ODN activate various immune effector cells, including NK cells.
  • CpG ODN enhance tumor immunization efficacy when used as adjuvants or to activate antigen-presenting cells.
  • CpG ODN alter malignant B-cell antigen expression and influence T-cell interactions.

Conclusions:

  • CpG ODN can activate immune effector cells involved in ADCC.
  • CpG ODN upregulate target antigens and may induce active immune responses.
  • CpG ODN show potential for enhancing antitumor monoclonal antibody (moAb) therapy efficacy, with ongoing clinical trials.

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...